Advertisement

The Scientist

» NIH funding and immunology

Most Recent

image: Too Many Applicants, Not Enough Money

Too Many Applicants, Not Enough Money

By | August 14, 2012

The rise in the amount of federal money requested through research grants is due to a rise in the overall number of applicants.

3 Comments

image: Sanctioned Psychiatrist Off Restriction

Sanctioned Psychiatrist Off Restriction

By | August 14, 2012

Charles Nemeroff, who was barred from receiving grants for 2 years in 2008, snags $401K from the NIH to study PTSD.

1 Comment

image: Immunologist Falsified Data

Immunologist Falsified Data

By | August 6, 2012

A researcher from the John Wayne Cancer Institute has settled his scientific misconduct case with the Office of Research Integrity.

9 Comments

image: Lymphatic Lines

Lymphatic Lines

By | August 1, 2012

Lymphatic vessels grow towards two chemokines, revealing signals that could be important in cancer metastasis.

0 Comments

image: Skin Microbes Alter Immunity

Skin Microbes Alter Immunity

By | July 30, 2012

Like commensal gut organisms, skin microbiota appear to help the mammalian immune system mature and stay regulated.

0 Comments

image: Tissue on Chips Galore

Tissue on Chips Galore

By | July 26, 2012

The National Institutes of Health will fund 17 projects developing lab-on-a-chip applications to improve drug screening.

1 Comment

image: Ubiquitin Chains in Action

Ubiquitin Chains in Action

By | July 1, 2012

Present in every tissue of the body, ubiquitin appears to be involved in a dizzying array of functions, from cell cycle and division to organelle and ribosome biogenesis, as well as the response to viral infection. The protein plays at least two role

0 Comments

image: NIH gets $100 Million More

NIH gets $100 Million More

By | June 14, 2012

The Senate approves an increase of about 0.3 percent for the 2013 NIH budget, but the Department of Energy doesn’t fare as well.

1 Comment

image: The Fungus Among Us

The Fungus Among Us

By | June 11, 2012

Researchers find a slew of new fungal species inhabiting the human gut, and suggest a link to an inflammatory bowel disease.

1 Comment

image: Parkinson's Vax Enters Clinical Trials

Parkinson's Vax Enters Clinical Trials

By | June 7, 2012

Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement